Zusammenfassung
Belastungsuntersuchungen bei Lungenkrankheiten sind bei sämtlichen Fragestellungen indiziert, die den Verdacht auf eine pulmonale Leistungslimitierung bei körperlicher Belastung beinhalten. Zusätzlich sollte jeder Patient mit dem klinischen Symptom Dyspnoe ergometrisch untersucht werden. Es handelt sich um eine wertvolle Ergänzung der pneumologischen Basisdiagnostik, die stets aus sorgfältiger Anamnese, dem klinischen Befund und einerLungenfunktionsprüfung im Ruhezustand bestehen sollte.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Anderson SD, Schoeffel RE. Respiratory heat and water loss during exercise in patients with asthma: effect of repeated exercise challenge. Eur J Respir Dis 1982; 63: 472–480
Anderson SD, Schoeffel RE, Black JL, Daviskas E. Airway cooling as the stimulus to exercise-induced asthma-a re-evaluation. Eur J Respir Dis 1985; 67: 20–30
Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008; 32: 1371–1385
Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT; American College of Chest Physicians. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132 [Suppl]: 161S–177S
Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999: this official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161: 309–329
Dumitrescu D, Rosenkranz S. Bedeutung der Spiroergometrie in der Diagnostik der pulmonalen Hypertonie. Dtsch Med Wochenschr 2008; 133 [Suppl 6]: S176–S179
Gläser S, Noga O, Koch B, Opitz CF, Schmidt B, Temmesfeld B, Dörr M, Ewert R, Schäper C. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med 2008 Sep 17. [Epub ahead of print]
Hansen JE, Wasserman K. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest. 1996; 109 (6): 1566–1576
Kawut SM, O’Shea MK, Bartels MN, Wilt JS, Sonett JR, Arcasoy SM. Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med 2005; 99 (11): 1431–1439
Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A, DeCamp MM, Benditt J, Sciurba F, Make B, Mohsenifar Z, Diaz P, Hoffman E, Wise R; NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173: 1326–1234
Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M, Nakanishi N, Miyatake K. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000; 161: 487–492
O’Donnell DE. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3: 180–184
Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167: 544–549
Older P, Hall A. Clinical review: how to identify high-risk surgical patients. Crit Care 2004; 8: 369–372.
Oudiz RJ. The role of exercise testing in the management of pulmonary arterial hypertension. Semin Respir Crit Care Med 2005; 26: 379–384
Rundell KW, Slee JB. Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes. J Allerg Clin Immunol 2008; 122: 238–246
Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001; 104: 429–435
Thomas M, Gatzemeier U, Goerg R, Matthiessen W, Morr H, Schoenfeld N, Ukena D, Stamatis G. Empfehlungen zur Diagnostik des Bronchialkarzinoms. Pneumologie 2000; 54: 361–371
Tolle JJ, Waxman AB, Van Horn TL, Pappagianopoulos PP, Systrom DM. Exercise-induced pulmonary arterial hypertension. Circulation 2008; 118: 2183–2189
Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ, ed. Principles of Exercise Testing and Interpretation. 4th edn. Lippincott Williams & Wilkins, Philadelphia, 2004
Wensel R, Opitz CF, Anker SD, Winkler J, Höffken G, Kleber FX, Sharma R, Hummel M, Hetzer R, Ewert R. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002; 106: 319–324
Yasunobu Y, Oudiz RJ, Sun XG, Hansen JE, Wasserman K. End-tidal pCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 2005; 127: 1637–1646
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Dumitrescu, D., Rosenkranz, S. (2010). Spiroergometrie bei Lungenkrankheiten. In: Löllgen, H., Erdmann, E., Gitt, A.K. (eds) Ergometrie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-92730-3_29
Download citation
DOI: https://doi.org/10.1007/978-3-540-92730-3_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-92729-7
Online ISBN: 978-3-540-92730-3
eBook Packages: Medicine (German Language)